Unknown OBSERVATIONAL NCT02060773

Effect of EGDT on Hepatic Perfusion in Patients With Septic Shock

Sponsor: Zhongda Hospital

Updated 7 times since 2017 Last updated: Feb 8, 2014 Started: Dec 31, 2012 Primary completion: Feb 28, 2014 Completion: Feb 28, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Septic Shock, this trial is ongoing. The trial is conducted by Zhongda Hospital and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Unknown Status NA
Jan 2017 — Feb 2017 [monthly]

Unknown Status NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhongda Hospital

Data source: Zhongda Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nanjing, China